Search

Author/Creator Zerbib, Robert

1. 483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. (9th November 2020)

Authors:
Demaria, Olivier; Carvelli, Julien; Benmansour, Nassima Chouaki; Fares, Joanna; Batista, Luciana; Thibult, Marie-Laure; Morel, Ariane; Carpentier, Sabrina; Remark, Romain; Represa, Agnes; Vely, Frederic; Ebbo, Mikael; Schleinitz, Nicolas; Zerbib, Robert; Morel, Yannis; Vivier, Eric; Demaria, Olivier
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A519
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. (9th November 2020)

Authors:
Demaria, Olivier; Carvelli, Julien; Benmansour, Nassima Chouaki; Fares, Joanna; Batista, Luciana; Thibult, Marie-Laure; Morel, Ariane; Carpentier, Sabrina; Remark, Romain; Represa, Agnes; Vely, Frederic; Ebbo, Mikael; Schleinitz, Nicolas; Zerbib, Robert; Morel, Yannis; Vivier, Eric; Demaria, Olivier
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A299
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

Authors:
Vlaar, Alexander P J; Witzenrath, Martin; van Paassen, Pieter; Heunks, Leo M A; Mourvillier, Bruno; de Bruin, Sanne; Lim, Endry H T; Brouwer, Matthijs C; Tuinman, Pieter R; Saraiva, José F K; Marx, Gernot; Lobo, Suzana M; Boldo, Rodrigo; Simon-Campos, Jesus A; Cornet, Alexander D; Grebenyuk, Anas...
Journal:
Lancet
Issue:
Volume 10:Issue 12(2022)
Page Start:
1137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab's Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia. (15th December 2022)

Authors:
Mourvillier, Bruno; Vlaar, Alexander; Witzenrath, Martin; Bauer, Michael; Heunks, Leo; Vasquez, Luis Hercilla; Welte, Tobias; van Paassen, Pieter; De Bruin, Sanne; Lim, Endry H T; Tuinman, Pieter R; Saraiva, Jose F; Marx, Gernot; Lobo, Suzana Margareth; Boldo, Rodrigo; Simón Campos, Jesus Abraham...
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗